Literature DB >> 17961092

T-regulatory lymphocytes and chronic viral hepatitis.

Simon M Rushbrook1, Matthew Hoare, Graeme J M Alexander.   

Abstract

Both hepatitis B virus (HBV) and hepatitis C virus (HCV) can cause persistent viral infection in humans. Chronic infection is associated with a risk of cirrhosis and hepatocellular carcinoma. The cause of chronic infection is unknown. A large body of evidence suggests that a failure of the adaptive immune response is critical in the establishment of chronic infection. Recently a new group of T cells (T-regulatory cells), that express CD4(+)CD25(+) and Foxp3, which can inhibit the cellular (CD4(+)/CD8(+)) immune response have been described. In this review the authors explore the thoughts regarding immune responses to HBV and HCV infections and the role of these T-regulatory cells in relation to the pathogenesis of chronic HBV and HCV infection and the potential for therapeutic intervention.

Entities:  

Mesh:

Year:  2007        PMID: 17961092     DOI: 10.1517/14712598.7.11.1689

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  9 in total

1.  CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis infection.

Authors:  Angela M Green; Joshua T Mattila; Carolyn L Bigbee; Kale S Bongers; P Ling Lin; Joanne L Flynn
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

2.  Changes in peripheral CD4+CD25(high) regulatory T cells in the acute-on-chronic liver failure patients with plasma exchange treatment.

Authors:  Wei-lin Mao; Yu-Feng Lou; Bo Ye; Sha Lin; Yue-mei Chen; Yu Chen
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

3.  Augmentation of hepatitis B virus-specific cellular immunity with programmed death receptor-1/programmed death receptor-L1 blockade in hepatitis B virus and HIV/hepatitis B virus coinfected patients treated with adefovir.

Authors:  Amy C Sherman; Nirupama Trehanpati; Marybeth Daucher; Richard T Davey; Henry Masur; Shiv Kumar Sarin; Shyam Kottilil; Anita Kohli
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-11       Impact factor: 2.205

Review 4.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 5.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

6.  Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.

Authors:  Julien Crettaz; Itziar Otano; Laura Ochoa-Callejero; Laura Ochoa; Alberto Benito; Astrid Paneda; Igor Aurrekoetxea; Pedro Berraondo; Juan Roberto Rodríguez-Madoz; Aurora Astudillo; Florian Kreppel; Stefan Kochanek; Juan Ruiz; Stephan Menne; Jesus Prieto; Gloria Gonzalez-Aseguinolaza
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

7.  Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.

Authors:  Agnieszka Kempinska-Podhorodecka; Malgorzata Milkiewicz; Urszula Wasik; Joanna Ligocka; Michał Zawadzki; Marek Krawczyk; Piotr Milkiewicz
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

8.  Chronic hepatitis C liver microenvironment: role of the Th17/Treg interplay related to fibrogenesis.

Authors:  Daniela Alejandra Rios; Pamela Valva; Paola Cecilia Casciato; Silvia Frias; María Soledad Caldirola; María Isabel Gaillard; Liliana Bezrodnik; Juan Bandi; Omar Galdame; Beatriz Ameigeiras; Diana Krasniansky; Carlos Brodersen; Eduardo Mullen; Elena Noemí De Matteo; María Victoria Preciado
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

9.  CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells.

Authors:  Cecilia Fernandez-Ponce; Margarita Dominguez-Villar; Enrique Aguado; Francisco Garcia-Cozar
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.